Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02266277 · ClinicalTrials.gov registry record · NA

System Alignment for VaccinE Delivery (SAVED): Improving Rates of Influenza and Pneumococcal Vaccination Through Patient Outreach, Improved Medical Record Accuracy and Targeted Physician Alerts

A NA study, sponsored by University of Massachusetts, Worcester.

Completed
Registry status
NA
Development phase
30,000
Enrollment target

NCT02266277 is a NA study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 30,000 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02266277, a NA study, has completed, sponsored by University of Massachusetts, Worcester.

COMPLETED
Registry status
NA
Development phase
30,000 participants
Enrollment target

Study Summary

The goal of this research study is to improve rates of appropriate influenza and pneumococcal vaccination among adults who receive care at a large multi-specialty group practice in central Massachusetts. The investigators plan to conduct a non-blinded randomized controlled trial during flu season 2014-2015 (Cycle 1). A total of 20,000 e-portal users and 10,000 non e-portal users who are identified in the Reliant Medical Group (RMG) Electronic Health Record (EHR) as not being up to date on their influenza vaccines will be randomized. E-portal users will be randomized to receive: * Arm 1: E-portal message with Interactive Voice Recognition (IVR) call * Arm 2: E-portal message with no IVR call * Arm 3: No e-portal message with IVR call OR * Arm 4: No e-portal message with no IVR call (Control, e-portal users) Non e-portal users will be randomized to receive either: * Arm 5: IVR call OR * Arm 6: no IVR call (Control, non e-portal users)

Interventions

  • OTHER Arm 1: E-portal message with IVR call
  • OTHER Arm 2: E-portal message with no IVR call
  • OTHER Arm 3: No e-portal message with IVR call
  • OTHER Arm 5: IVR call

Trial Details

FieldValue
Enrollment Target 30,000 participants
Start Date 2014-11
Est. Completion 2016-12
Phase NA

What the Registry Record Tells You About NCT02266277

The ClinicalTrials.gov registry entry for NCT02266277 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Arm 1: E-portal message with IVR call is the first listed.

NCT02266277 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02266277 about?

NCT02266277 is a clinical study titled "System Alignment for VaccinE Delivery (SAVED): Improving Rates of Influenza and Pneumococcal Vaccination Through Patient Outreach, Improved Medical Record Accuracy and Targeted Physician Alerts". The goal of this research study is to improve rates of appropriate influenza and pneumococcal vaccination among adults who receive care at a large multi-specialty group practice in central Massachusetts. The investigators plan to conduct a non-blinded randomized controlled trial during flu season 2...

What is the current status of trial NCT02266277?

This trial is currently completed. It is a NA study. The enrollment target is 30,000 participants. The study started on 2014-11. Estimated completion is 2016-12.

What interventions are being tested in trial NCT02266277?

The interventions under investigation include: Arm 1: E-portal message with IVR call (OTHER), Arm 2: E-portal message with no IVR call (OTHER), Arm 3: No e-portal message with IVR call (OTHER), Arm 5: IVR call (OTHER).

Who is sponsoring clinical trial NCT02266277?

This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.